{"transactions":[{"id":4616791,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:03:45.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":23442,"derivative":{"exercise_price":0.46,"expiration_date":"2036-09-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-390532","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526390532/ownership.xml","form_type":"4"}},{"id":4616784,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:03:10.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":54042,"derivative":{"exercise_price":0.46,"expiration_date":"2036-09-10","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001193125-26-390528","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000119312526390528/ownership.xml","form_type":"4"}},{"id":4616777,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:02:29.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":23338,"derivative":{"exercise_price":0.46,"expiration_date":"2036-09-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-390521","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000119312526390521/ownership.xml","form_type":"4"}},{"id":4616759,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-14T20:01:45.000Z","date":"2026-09-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) September 10, 2027 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":23287,"derivative":{"exercise_price":0.46,"expiration_date":"2036-09-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001193125-26-390520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1743173/000119312526390520/ownership.xml","form_type":"4"}},{"id":1152457,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-12T20:56:01.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":33987,"derivative":{"exercise_price":3.88,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-069633","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017025069633/ownership.xml","form_type":"4"}},{"id":1152919,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-12T20:48:31.000Z","date":"2025-05-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":37975,"derivative":{"exercise_price":3.88,"expiration_date":"2035-05-09","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000950170-25-069626","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017025069626/ownership.xml","form_type":"4"}},{"id":1282300,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-05T19:34:41.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.49,"value":1743.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from August 1, 2022 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower."}],"balance_after":2681,"source":{"system":"sec-edgar","filing":"0000950170-25-014814","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017025014814/ownership.xml","form_type":"4"}},{"id":1282790,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-02-05T19:24:18.000Z","date":"2025-02-03","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.49,"value":1743.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/25 at a per share purchase price of $2.49 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2025. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the respective offering date or purchase date, whichever is lower."}],"balance_after":2819,"source":{"system":"sec-edgar","filing":"0000950170-25-014802","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017025014802/ownership.xml","form_type":"4"}},{"id":1426480,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:41:04.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13442,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099644","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024099644/ownership.xml","form_type":"4"}},{"id":1426479,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:32:31.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13338,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099639","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024099639/ownership.xml","form_type":"4"}},{"id":1426478,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:26:01.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13287,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099625","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024099625/ownership.xml","form_type":"4"}},{"id":1426477,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88116,"kind":"person","name":"Carosella Deborah D","position":1,"cik":"0001701600","reported_name":"Carosella Deborah D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:20:24.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13255,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000095017024099621/ownership.xml","form_type":"4"}},{"id":1426501,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50108,"kind":"person","name":"Bolles Albert D.","position":1,"cik":"0001603163","reported_name":"Bolles Albert D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T23:14:13.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":10909,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":13394,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":10909},"source":{"system":"sec-edgar","filing":"0000950170-24-099619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603163/000095017024099619/ownership.xml","form_type":"4"}},{"id":1426558,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T19:06:39.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":25455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) August 19, 2025 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":31042,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":25455},"source":{"system":"sec-edgar","filing":"0000950170-24-099617","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000095017024099617/ownership.xml","form_type":"4"}},{"id":1426692,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T18:26:11.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":21487,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-099605","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017024099605/ownership.xml","form_type":"4"}},{"id":1426961,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-21T18:09:33.000Z","date":"2024-08-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 8/19/2024 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":25475,"derivative":{"exercise_price":2.71,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000950170-24-099593","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024099593/ownership.xml","form_type":"4"}},{"id":1427942,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79919,"kind":"person","name":"Kawakami Mark","position":1,"cik":"0002030709","reported_name":"Kawakami Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:11:11.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2022 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":1981,"source":{"system":"sec-edgar","filing":"0000950170-24-099338","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2030709/000095017024099338/ownership.xml","form_type":"4"}},{"id":1428322,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:05:54.000Z","date":"2024-08-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to August 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":2119,"source":{"system":"sec-edgar","filing":"0000950170-24-099335","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024099335/ownership.xml","form_type":"4"}},{"id":1659946,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-05T16:29:56.000Z","date":"2024-02-01","kind":"purchase","planned":false,"acquired":true,"shares":700,"price":2.06,"value":1442.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/24 at a per share purchase price of $2.06 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2024. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":1419,"source":{"system":"sec-edgar","filing":"0000950170-24-011271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000095017024011271/ownership.xml","form_type":"4"}},{"id":1814185,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-08-07T19:55:36.000Z","date":"2023-08-04","kind":"purchase","planned":false,"acquired":true,"shares":649,"price":3.67,"value":2381.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 649 shares of the Issuer's common stock on 8/1/23 at a per share purchase price of $3.67 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to August 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":719,"source":{"system":"sec-edgar","filing":"0001209191-23-044889","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123044889/doc4.xml","form_type":"4"}},{"id":1852060,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88116,"kind":"person","name":"Carosella Deborah D","position":1,"cik":"0001701600","reported_name":"Carosella Deborah D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:19:24.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2346,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037763","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123037763/doc4.xml","form_type":"4"}},{"id":1852059,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:13:47.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2533,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037761","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123037761/doc4.xml","form_type":"4"}},{"id":1852166,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50108,"kind":"person","name":"Bolles Albert D.","position":1,"cik":"0001603163","reported_name":"Bolles Albert D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T17:06:33.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2485,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603163/000120919123037757/doc4.xml","form_type":"4"}},{"id":1852058,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:59:44.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2429,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037752","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123037752/doc4.xml","form_type":"4"}},{"id":1852057,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T16:51:42.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":2378,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":937},"source":{"system":"sec-edgar","filing":"0001209191-23-037750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123037750/doc4.xml","form_type":"4"}},{"id":1852311,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T12:40:28.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":2186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 6, 2024 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":5587,"derivative":{"exercise_price":4.8,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":2186},"source":{"system":"sec-edgar","filing":"0001209191-23-037748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919123037748/doc4.xml","form_type":"4"}},{"id":1874773,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":112998,"kind":"person","name":"Jacot Stanley Jr","position":1,"cik":"0001909085","reported_name":"Jacot Stanley Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2023-05-30T22:24:20.000Z","date":"2023-05-30","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.31,"value":21550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $4.27 to $4.35. The price reported above reflects the weighted average purchase price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-23-032996","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123032996/doc4.xml","form_type":"4"}},{"id":1911274,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":112998,"kind":"person","name":"Jacot Stanley Jr","position":1,"cik":"0001909085","reported_name":"Jacot Stanley Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T21:26:13.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":9402,"derivative":{"exercise_price":7.55,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-23-026080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919123026080/doc4.xml","form_type":"4"}},{"id":1911458,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":114090,"kind":"person","name":"PITLIK LAURA","position":1,"cik":"0001872366","reported_name":"PITLIK LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T17:30:32.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":5300,"derivative":{"exercise_price":7.55,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-23-026082","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872366/000120919123026082/doc4.xml","form_type":"4"}},{"id":1911720,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T17:24:47.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 4/4/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":5475,"derivative":{"exercise_price":7.55,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001209191-23-026079","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123026079/doc4.xml","form_type":"4"}},{"id":2037285,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-02T19:07:29.000Z","date":"2023-02-01","kind":"purchase","acquired":true,"shares":700,"price":0.23,"value":161.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/1/23 at a per share purchase price of $0.23 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase periods from February 1, 2021 to February 1, 2023. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":2800,"source":{"system":"sec-edgar","filing":"0001209191-23-006429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123006429/doc4.xml","form_type":"4"}},{"id":2064355,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":79957,"kind":"person","name":"Schaefer Thomas J.","position":1,"cik":"0001960808","reported_name":"Schaefer Thomas J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-05T21:07:57.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options were granted on 1/3/2023 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs."}],"balance_after":159000,"derivative":{"exercise_price":0.28,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-002182","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1960808/000120919123002182/doc4.xml","form_type":"4"}},{"id":2179482,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-19T00:56:57.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in two equal installments occurring on the first, and second anniversary of the date of grant."}],"balance_after":255313,"derivative":{"exercise_price":0.94,"expiration_date":"2032-08-16","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-046792","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122046792/doc4.xml","form_type":"4"}},{"id":2179746,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":114090,"kind":"person","name":"PITLIK LAURA","position":1,"cik":"0001872366","reported_name":"PITLIK LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-08-18T21:00:24.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in two equal installments occurring on the first, and second anniversary of the date of grant."}],"balance_after":152000,"derivative":{"exercise_price":0.94,"expiration_date":"2032-08-16","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-046793","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872366/000120919122046793/doc4.xml","form_type":"4"}},{"id":2195677,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-03T21:23:20.000Z","date":"2022-08-01","kind":"purchase","acquired":true,"shares":700,"price":0.7,"value":490.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/1/22 at a per share purchase price of $0.70 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan (\"ESPP\"). This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount includes the 2015 Employee Stock Purchase Plan (\"ESPP\") purchases, for the purchase period of August 4, 2020 to August 1, 2022. These transactions were exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of Issuer's Common Stock on the date of each respective purchase."}],"balance_after":5088,"source":{"system":"sec-edgar","filing":"0001209191-22-044269","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122044269/doc4.xml","form_type":"4"}},{"id":2244667,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50108,"kind":"person","name":"Bolles Albert D.","position":1,"cik":"0001603163","reported_name":"Bolles Albert D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:49:39.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":62018,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-034126","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603163/000120919122034126/doc4.xml","form_type":"4"}},{"id":2244541,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T20:44:44.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":57765,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-034108","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122034108/doc4.xml","form_type":"4"}},{"id":2244539,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T18:25:38.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":59777,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-033912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122033912/doc4.xml","form_type":"4"}},{"id":2244540,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T17:23:45.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":63931,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-033874","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122033874/doc4.xml","form_type":"4"}},{"id":2244831,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T16:54:06.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":55114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":136239,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":55114},"source":{"system":"sec-edgar","filing":"0001209191-22-034139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919122034139/doc4.xml","form_type":"4"}},{"id":2244538,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88116,"kind":"person","name":"Carosella Deborah D","position":1,"cik":"0001701600","reported_name":"Carosella Deborah D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-03T16:49:11.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":23620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2023 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":56408,"derivative":{"exercise_price":1.34,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":23620},"source":{"system":"sec-edgar","filing":"0001209191-22-033860","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122033860/doc4.xml","form_type":"4"}},{"id":2297691,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-13T19:55:12.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in two equal installments occurring on the first, and second anniversary of the date of grant."}],"balance_after":232313,"derivative":{"exercise_price":1.27,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001209191-22-024267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122024267/doc4.xml","form_type":"4"}},{"id":2297690,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-13T19:55:12.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":232313,"derivative":{"exercise_price":1.27,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-024267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122024267/doc4.xml","form_type":"4"}},{"id":2297865,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":114090,"kind":"person","name":"PITLIK LAURA","position":1,"cik":"0001872366","reported_name":"PITLIK LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-13T16:01:34.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":23000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Option vests in two equal installments occurring on the first, and second anniversary of the date of grant, subject to the Participant's continued service."}],"balance_after":129000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":23000},"source":{"system":"sec-edgar","filing":"0001209191-22-024268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1872366/000120919122024268/doc4.xml","form_type":"4"}},{"id":2297864,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":114090,"kind":"person","name":"PITLIK LAURA","position":1,"cik":"0001872366","reported_name":"PITLIK LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-13T16:01:34.000Z","date":"2022-04-11","kind":"grant","acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":129000,"derivative":{"exercise_price":1.27,"expiration_date":"2032-04-11","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001209191-22-024268","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872366/000120919122024268/doc4.xml","form_type":"4"}},{"id":2411628,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":112998,"kind":"person","name":"Jacot Stanley Jr","position":1,"cik":"0001909085","reported_name":"Jacot Stanley Jr","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-04T19:01:20.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":316108,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":316108,"derivative":{"exercise_price":0.91,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":316108},"source":{"system":"sec-edgar","filing":"0001209191-22-007154","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919122007154/doc4.xml","form_type":"4"}},{"id":2635039,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":114090,"kind":"person","name":"PITLIK LAURA","position":1,"cik":"0001872366","reported_name":"PITLIK LAURA","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Marketing Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-07-13T18:33:49.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":75000,"derivative":{"exercise_price":2.8,"expiration_date":"2031-07-12","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-21-046592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1872366/000120919121046592/doc4.xml","form_type":"4"}},{"id":2680867,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T20:17:33.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":40311,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038217","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121038217/doc4.xml","form_type":"4"}},{"id":2680864,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T20:14:26.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":34145,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121038203/doc4.xml","form_type":"4"}},{"id":2680865,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88116,"kind":"person","name":"Carosella Deborah D","position":1,"cik":"0001701600","reported_name":"Carosella Deborah D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T20:10:56.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":32788,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121038196/doc4.xml","form_type":"4"}},{"id":2680863,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T19:59:50.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":36157,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038167","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121038167/doc4.xml","form_type":"4"}},{"id":2680925,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50108,"kind":"person","name":"Bolles Albert D.","position":1,"cik":"0001603163","reported_name":"Bolles Albert D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T19:48:18.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":10935,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":38398,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":10935},"source":{"system":"sec-edgar","filing":"0001209191-21-038166","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603163/000120919121038166/doc4.xml","form_type":"4"}},{"id":2680983,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T16:06:57.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":25514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 2, 2022 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":81124,"derivative":{"exercise_price":2.89,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":25514},"source":{"system":"sec-edgar","filing":"0001209191-21-038190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919121038190/doc4.xml","form_type":"4"}},{"id":2703496,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":139195,"kind":"person","name":"Cuvelier Chris","position":1,"cik":"0001863255","reported_name":"Cuvelier Chris","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Growth Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-05-20T16:38:08.000Z","date":"2021-05-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the total number of shares subject to the Option will vest on the first anniversary of the date of the award; the remaining 75% will vest in 36 equal installments, subject to the Participant's continued service."}],"balance_after":100000,"derivative":{"exercise_price":2.61,"expiration_date":"2031-05-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-034432","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863255/000120919121034432/doc4.xml","form_type":"4"}},{"id":2835796,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88116,"kind":"person","name":"Carosella Deborah D","position":1,"cik":"0001701600","reported_name":"Carosella Deborah D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-24T21:23:37.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":21853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date."}],"balance_after":21853,"derivative":{"exercise_price":3.25,"expiration_date":"2031-02-22","underlying":"Common Stock","underlying_shares":21853},"source":{"system":"sec-edgar","filing":"0001209191-21-013784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121013784/doc4.xml","form_type":"4"}},{"id":2897637,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T23:51:36.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service."}],"balance_after":435450,"derivative":{"exercise_price":3.05,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001209191-21-005219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005219/doc4.xml","form_type":"4"}},{"id":2897636,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-25T23:51:36.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":585,"price":3.16,"value":1848.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 585 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":14285,"source":{"system":"sec-edgar","filing":"0001209191-21-005219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005219/doc4.xml","form_type":"4"}},{"id":2897633,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T23:43:50.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service."}],"balance_after":144313,"derivative":{"exercise_price":3.05,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-21-005213","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005213/doc4.xml","form_type":"4"}},{"id":2897632,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-25T23:43:50.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":700,"price":3.16,"value":2212.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":2638,"source":{"system":"sec-edgar","filing":"0001209191-21-005213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919121005213/doc4.xml","form_type":"4"}},{"id":2897942,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-25T18:47:58.000Z","date":"2021-01-21","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest monthly in equal installments over a period of four years from the date of the grant, 01/21/2021, subject to the Participant's continued service."}],"balance_after":115000,"derivative":{"exercise_price":3.05,"expiration_date":"2031-01-21","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-21-005218","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919121005218/doc4.xml","form_type":"4"}},{"id":2897941,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Common Stock","published_at":"2021-01-25T18:47:58.000Z","date":"2020-08-03","kind":"purchase","acquired":true,"shares":700,"price":3.16,"value":2212.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's Common Stock on 8/3/20 at a per share purchase price of $3.16 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-21-005218","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919121005218/doc4.xml","form_type":"4"}},{"id":3084923,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T17:19:13.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."}],"balance_after":23210,"derivative":{"exercise_price":3.73,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":753},"source":{"system":"sec-edgar","filing":"0001209191-20-042124","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120042124/doc4.xml","form_type":"4"}},{"id":3084968,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T13:20:38.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":5273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on July 8, 2021."}],"balance_after":55610,"derivative":{"exercise_price":3.73,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":5273},"source":{"system":"sec-edgar","filing":"0001209191-20-042125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919120042125/doc4.xml","form_type":"4"}},{"id":3123948,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88118,"kind":"person","name":"Yoder Amy","position":1,"cik":"0001402263","reported_name":"Yoder Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T15:13:15.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":29376,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001209191-20-033828","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120033828/doc4.xml","form_type":"4"}},{"id":3123947,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T15:12:37.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":22457,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001209191-20-033827","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120033827/doc4.xml","form_type":"4"}},{"id":3124062,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50108,"kind":"person","name":"Bolles Albert D.","position":1,"cik":"0001603163","reported_name":"Bolles Albert D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T15:10:40.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":27463,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001209191-20-033825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1603163/000120919120033825/doc4.xml","form_type":"4"}},{"id":3123946,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":50851,"kind":"person","name":"WALLER GREGORY D","position":1,"cik":"0001204144","reported_name":"WALLER GREGORY D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T15:09:56.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":9137,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":25222,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":9137},"source":{"system":"sec-edgar","filing":"0001209191-20-033824","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120033824/doc4.xml","form_type":"4"}},{"id":3124334,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-03T11:11:26.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":21320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become 100% vested and exercisable on the earlier to occur of (i) June 1, 2021 or (ii) the date of the Issuer's next Annual Meeting of Stockholders, subject to the Participant's continued service."}],"balance_after":50338,"derivative":{"exercise_price":3.69,"expiration_date":"2030-06-01","underlying":"Common Stock","underlying_shares":21320},"source":{"system":"sec-edgar","filing":"0001209191-20-033826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919120033826/doc4.xml","form_type":"4"}},{"id":3183847,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":143532,"kind":"person","name":"Shultz Randall","position":1,"cik":"0001808500","reported_name":"Shultz Randall","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-03T17:31:36.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 48 equal installments beginning April 30, 2020 and ending March 31, 2024."}],"balance_after":60000,"derivative":{"exercise_price":2.74,"expiration_date":"2030-04-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-20-023345","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808500/000120919120023345/doc4.xml","form_type":"4"}},{"id":3291593,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T21:14:26.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024."}],"balance_after":58588,"derivative":{"exercise_price":4.91,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-20-006294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006294/doc4.xml","form_type":"4"}},{"id":3291592,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":109933,"kind":"person","name":"Haley Pamela","position":1,"cik":"0001787373","reported_name":"Haley Pamela","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-02-04T21:14:26.000Z","date":"2020-02-03","kind":"purchase","acquired":true,"shares":700,"price":1.72,"value":1204.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":1938,"source":{"system":"sec-edgar","filing":"0001209191-20-006294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006294/doc4.xml","form_type":"4"}},{"id":3291591,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":138411,"kind":"person","name":"Reiter Sarah","position":1,"cik":"0001734605","reported_name":"Reiter Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T21:13:37.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024."}],"balance_after":121705,"derivative":{"exercise_price":4.91,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-20-006290","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006290/doc4.xml","form_type":"4"}},{"id":3291590,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":138411,"kind":"person","name":"Reiter Sarah","position":1,"cik":"0001734605","reported_name":"Reiter Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2020-02-04T21:13:37.000Z","date":"2020-02-03","kind":"purchase","acquired":true,"shares":700,"price":1.72,"value":1204.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001209191-20-006290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006290/doc4.xml","form_type":"4"}},{"id":3291589,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-04T21:11:21.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":76000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 48 equal installments beginning February 29, 2020 and ending January 31, 2024."}],"balance_after":185450,"derivative":{"exercise_price":4.91,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":76000},"source":{"system":"sec-edgar","filing":"0001209191-20-006282","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/doc4.xml","form_type":"4"}},{"id":3291588,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-04T21:11:21.000Z","date":"2020-02-03","kind":"purchase","acquired":true,"shares":700,"price":1.72,"value":1204.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the purchase of 700 shares of the Issuer's common stock on 2/3/20 at a per share purchase price of $1.72 pursuant to participation in the Issuer's 2015 Employee Stock Purchase Plan."}],"balance_after":13700,"source":{"system":"sec-edgar","filing":"0001209191-20-006282","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919120006282/doc4.xml","form_type":"4"}},{"id":3332504,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":138411,"kind":"person","name":"Reiter Sarah","position":1,"cik":"0001734605","reported_name":"Reiter Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-12-23T21:50:01.000Z","date":"2019-12-23","kind":"purchase","acquired":true,"shares":900,"price":5.95,"value":5355.0,"ownership":{"direct":true},"balance_after":3100,"source":{"system":"sec-edgar","filing":"0001209191-19-061814","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119061814/doc4.xml","form_type":"4"}},{"id":3364121,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":138411,"kind":"person","name":"Reiter Sarah","position":1,"cik":"0001734605","reported_name":"Reiter Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-11-20T14:00:11.000Z","date":"2019-11-19","kind":"purchase","acquired":true,"shares":1000,"price":4.52,"value":4520.0,"ownership":{"direct":true},"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001209191-19-057375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119057375/doc4.xml","form_type":"4"}},{"id":3365878,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88117,"kind":"person","name":"Murray Lilian Shackelford","position":1,"cik":"0001743173","reported_name":"Murray Lilian Shackelford","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2019-11-19T15:50:54.000Z","date":"2019-11-18","kind":"purchase","acquired":true,"shares":5000,"price":4.25,"value":21250.0,"ownership":{"direct":true},"balance_after":8524,"source":{"system":"sec-edgar","filing":"0001209191-19-057084","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119057084/doc4.xml","form_type":"4"}},{"id":3368161,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common stock","published_at":"2019-11-18T18:32:26.000Z","date":"2019-11-14","kind":"purchase","acquired":true,"shares":1000,"price":4.0795,"value":4079.5,"ownership":{"direct":true},"balance_after":13000,"source":{"system":"sec-edgar","filing":"0001209191-19-056884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119056884/doc4.xml","form_type":"4"}},{"id":3407822,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-23T23:18:40.000Z","date":"2019-09-23","kind":"purchase","acquired":true,"shares":2000,"price":5.25,"value":10500.0,"ownership":{"direct":true},"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001209191-19-050493","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119050493/doc4.xml","form_type":"4"}},{"id":3412410,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-17T19:54:26.000Z","date":"2019-09-17","kind":"purchase","acquired":true,"shares":5000,"price":5.8776,"value":29388.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-19-049954","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919119049954/doc4.xml","form_type":"4"}},{"id":3418511,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-10T22:24:24.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":1000,"price":6.5205,"value":6520.5,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001209191-19-049077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/doc4.xml","form_type":"4"}},{"id":3418510,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2019-09-10T22:24:24.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":1000,"price":6.493,"value":6493.0,"ownership":{"direct":true},"balance_after":9000,"source":{"system":"sec-edgar","filing":"0001209191-19-049077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119049077/doc4.xml","form_type":"4"}},{"id":3418509,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":138411,"kind":"person","name":"Reiter Sarah","position":1,"cik":"0001734605","reported_name":"Reiter Sarah","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-09-10T22:02:46.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":1200,"price":6.48,"value":7776.0,"ownership":{"direct":true},"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001209191-19-049070","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119049070/doc4.xml","form_type":"4"}},{"id":3418699,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-10T17:57:55.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":10000,"price":6.49,"value":64900.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001209191-19-049067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919119049067/doc4.xml","form_type":"4"}},{"id":3418698,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":88123,"kind":"person","name":"Comcowich Kevin","position":1,"cik":"0001688770","reported_name":"Comcowich Kevin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-10T17:57:55.000Z","date":"2019-09-10","kind":"purchase","acquired":true,"shares":5000,"price":6.4866,"value":32433.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-049067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1688770/000120919119049067/doc4.xml","form_type":"4"}},{"id":3427349,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-28","kind":"purchase","acquired":true,"shares":1000,"price":6.88,"value":6880.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427348,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":2000,"price":8.93,"value":17860.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427347,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":8.95,"value":8950.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427346,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":9.3,"value":9300.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427345,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-27","kind":"purchase","acquired":true,"shares":1000,"price":9.32,"value":9320.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427344,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-26","kind":"purchase","acquired":true,"shares":1000,"price":9.22,"value":9220.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427343,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T17:01:43.000Z","date":"2019-08-26","kind":"purchase","acquired":true,"shares":1000,"price":8.33,"value":8330.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-19-047582","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047582/doc4a.xml","form_type":"4/A","original_submission_date":"2019-08-28"}},{"id":3427322,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":1000,"price":6.88,"value":6880.0,"ownership":{"direct":true},"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427321,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":2000,"price":8.93,"value":17860.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427320,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":8.95,"value":8950.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427319,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":9.3,"value":9300.0,"ownership":{"direct":true},"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427318,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-27","kind":"grant","acquired":true,"shares":1000,"price":9.32,"value":9320.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427317,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":1000,"price":9.22,"value":9220.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}},{"id":3427316,"issuer":{"id":8593,"kind":"organization","name":"Arcadia Biosciences, Inc.","symbol":"RKDA"},"owners":[{"id":52696,"kind":"person","name":"Plavan Matthew T","position":1,"cik":"0001326765","reported_name":"Plavan Matthew T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-28T14:31:01.000Z","date":"2019-08-26","kind":"grant","acquired":true,"shares":1000,"price":8.33,"value":8330.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001209191-19-047580","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1469443/000120919119047580/doc4.xml","form_type":"4"}}],"next_cursor":"2019-08-28T14:31:01.000000Z,3427316"}